Close Menu

Takara Bio

A week after announcing 2013 revenues of $1.3 million — more than double its 2012 revenues — WaferGen Biosystems this week set a lofty goal of more than $5 million for its top line in 2014

Trovagene said this week that Charles Cantor has joined the company's scientific advisory board.

NEW YORK (GenomeWeb News) – WaferGen Biosystems reported after the close of the market on Thursday a 55 percent jump in its fourth quarter revenues.

This article has been updated with comments from AltheaDx.

WaferGen Biosystems has shuffled and reduced the size of its board of directors to seven from nine following the firm's acquisition of IntegenX's next-g

WaferGen has made changes to its board of directors following the

NEW YORK (GenomeWeb News) — WaferGen Biosystems said today that it has acquired the next-generation sequencing library preparation business of IntegenX.

NEW YORK (GenomeWeb News) – Wafergen Biosystems today said that revenues in its third quarter more than doubled year over year.

Clontech Laboratories has launched its SMARTer Stranded RNA-seq kit for strand-specific RNA-seq from low-input samples.

Fresh off of a $15 million private placement and restructuring transaction intended to simplify its capital structure, WaferGen Biosystems has shifted its focus to position itself as a provider of tools to supplement next-generation sequencing.

Pages

Nature News examines how science in the UK may fare as Boris Johnson, the next prime minister, pursues Brexit.

CNN reports that Immigration and Customs Enforcement in the US has expanded its DNA testing to seven sites along the southern border.

In PNAS this week: role for exosomes in neuronal circuit development, tuberculosis pathogen enzymes, and more.

Undoing Obamacare protections could affect people's willingness to undergo genetic testing, Sarah Lawrence College's Laura Hercher and the University of Iowa College of Law's Anya Prince write at BuzzFeed News.